|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.52 USD | +3.17% |
|
+9.17% | -7.42% |
| Jul. 03 | Nordic stocks in North America, Ericsson fell 1.6% | FW |
| Jul. 01 | Nordic stocks in North America, AstraZeneca rose 1.3% | FW |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 35.82x | 6.58x | 0.9x | 9.04x | 28.05x | 28.7x | 0.05% | 59.1B | |
| 20.71x | 3.96x | -2.22x | 6.39x | 13.83x | 16.06x | 1.45% | 55.19B | |
| -19.36x | 1.19x | 3.07x | 4.94x | -8.63x | -7.08x | -.--% | 24.67B | |
| -42.26x | 56.69x | 0.72x | 14x | -40.82x | -43.92x | -.--% | 24.19B | |
| 24.52x | 2.41x | 1.72x | 4.85x | 12.6x | 15.16x | -.--% | 19.69B | |
| 48.53x | 13x | 0.44x | 19.97x | 52.67x | 47.48x | 0.06% | 16.22B | |
| 17.56x | 4.99x | 1.22x | 5.1x | 11.91x | 13.06x | -.--% | 14.04B | |
| -520.97x | 21.38x | 10.57x | 35.77x | -3987.51x | -391.47x | -.--% | 14.84B | |
| -75.74x | 27.09x | 1.66x | 7.79x | -69.83x | -55.94x | -.--% | 12.18B | |
| -13.63x | 160.38x | 0.66x | 3552.08x | -16.52x | -13.48x | -.--% | 11.97B | |
| -26.61x | 27.31x | -0x | 24.43x | -31.36x | -25.37x | -.--% | 11.83B | |
| -13.41x | -91.64x | 9.72x | 102.6x | -15.35x | -14.88x | -.--% | 11.74B | |
| 2212.15x | 8.48x | -21.42x | 15.01x | 96.01x | 323.35x | -.--% | 12.03B | |
| -11.11x | - | -0.09x | - | - | - | - | 9.89B | |
| -21.57x | 8.27x | 10.98x | 799.28x | -18.75x | -18.66x | -.--% | 9.77B | |
| 12.98x | 6.21x | 0.04x | 9.23x | 14.94x | 13.71x | -.--% | 10.06B | |
| 22.26x | 6.05x | 1.06x | - | - | - | 0.35% | 8.68B | |
| -6.86x | - | -0.13x | - | -7.03x | -6.47x | -.--% | 8.43B | |
| -28.19x | 7.75x | -0.51x | - | -25.45x | -24.62x | -.--% | 7.52B | |
| Average | 84.99x | 15.89x | 0.97x | 307.36x | -234.78x | -8.49x | 0.11% | 18B | |
| Weighted average by Cap. | 59.43x | 13.92x | 0.69x | 177.41x | -177.44x | -2.85x | 0.26% |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
